North American Vaccine adds new product to R&D pipeline; U.S. patent issues March 8, 1999 No Comments
Licensing opportunity from BTG: fatty acid-peptide conjugates for use in vaccines March 5, 1999 No Comments
Praxis purchases intellectual property allowing development of antirejection drug March 4, 1999 No Comments